ACADIA Pharmaceuticals Inc (ACAD)
16.18
-0.09
(-0.55%)
USD |
NASDAQ |
Nov 21, 16:00
16.20
+0.02
(+0.09%)
After-Hours: 20:00
ACADIA Pharmaceuticals Profit Margin (Quarterly): 13.08% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 13.08% |
| June 30, 2024 | 13.80% |
| March 31, 2024 | 8.04% |
| December 31, 2023 | 19.82% |
| September 30, 2023 | -30.79% |
| June 30, 2023 | 0.67% |
| March 31, 2023 | -36.32% |
| December 31, 2022 | -30.57% |
| September 30, 2022 | -20.80% |
| June 30, 2022 | -25.28% |
| March 31, 2022 | -97.91% |
| December 31, 2021 | -32.96% |
| September 30, 2021 | -10.98% |
| June 30, 2021 | -38.08% |
| March 31, 2021 | -62.36% |
| December 31, 2020 | -55.17% |
| September 30, 2020 | -70.21% |
| June 30, 2020 | -38.27% |
| March 31, 2020 | -97.73% |
| December 31, 2019 | -53.94% |
| September 30, 2019 | -44.38% |
| June 30, 2019 | -66.03% |
| March 31, 2019 | -135.5% |
| December 31, 2018 | -109.9% |
| September 30, 2018 | -106.6% |
| Date | Value |
|---|---|
| June 30, 2018 | -110.9% |
| March 31, 2018 | -111.1% |
| December 31, 2017 | -158.1% |
| September 30, 2017 | -183.4% |
| June 30, 2017 | -221.3% |
| March 31, 2017 | -574.7% |
| December 31, 2016 | -657.9% |
| September 30, 2016 | -1.36K% |
| June 30, 2016 | -73.53K% |
| March 31, 2016 | -1.24M% |
| December 31, 2015 | -269.3K% |
| September 30, 2015 | -99.76K% |
| June 30, 2015 | -3.94M% |
| March 31, 2015 | -1.01M% |
| December 31, 2014 | -59.10K% |
| September 30, 2014 | -165.2K% |
| June 30, 2014 | -76.77K% |
| March 31, 2014 | -59.43K% |
| December 31, 2013 | -32.56K% |
| September 30, 2013 | -4.46K% |
| June 30, 2013 | -2.01K% |
| March 31, 2013 | -1.47K% |
| December 31, 2012 | -1.79K% |
| September 30, 2012 | -69.06% |
| June 30, 2012 | -904.7% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-97.91%
Minimum
Mar 2022
19.82%
Maximum
Dec 2023
-32.30%
Average
-31.87%
Median
Profit Margin (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 10.18% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 27.32% |
| Return on Assets | 15.57% |
| Return on Invested Capital | 27.32% |
| Gross Profit Margin (Quarterly) | 92.47% |
| Operating Margin (Quarterly) | 12.64% |
| Return on Net Operating Assets | 37.41% |